
News|Articles|March 1, 2024
An ophthalmologist with personal experience has explored the impact of AI-driven solutions
Advertisement
Advertorial: An ophthalmologist with personal experience has explored the impact of AI-driven solutions
Dr. Alberto Piatti, the chief ophthalmologist of the diabetic center at the A.S.L T05 health district in Turin, Italy has been actively engaged in diabetic retinopathy (DR) screenings for decades. In 2019, the health center implemented an integrated DR care pathway between diabetologists and ophthalmologists. The aim was to introduce advancements such as telemedicine and utilizing arti icial intelligence. According to Dr. Piatti, technological improvements and especially AI have radically transformed DR screening.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
2026 Nobel Prize in Physiology or Medicine awarded for optogenetics discovery
2
Oku Digital Health launches from Topcon to link eye care, primary care
3
EURETINA 2026: Optogenetic therapy MCO-010 aims to restore vision in advanced macular disease
4
Real-world VOYAGER data on faricimab in nAMD, DME, RVO at EURETINA 2026
5


















